Phase 2 Study of Fosbretabulin Tromethamine (CA4P) for the Treatment of Well-Differentiated, Low-to-Intermediate-Grade Unresectable, Recurrent or Metastatic Pancreatic or Gastrointestinal Neuroendocrine Tumors/Carcinoid with Elevated Biomarkers Libutti, S. K., Anthony, L., Sosa, J., Kunz, P., Thomas, J., Cruikshank, S., Varga, A., Chaplin, D. J., Burke, J., Wolin, E. M. LIPPINCOTT WILLIAMS & WILKINS. 2016: 478

View details for Web of Science ID 000370956600059